BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 28416444)

  • 1. The pharmacology of voltage-gated sodium channel activators.
    Deuis JR; Mueller A; Israel MR; Vetter I
    Neuropharmacology; 2017 Dec; 127():87-108. PubMed ID: 28416444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Snake with the Scorpion's Sting: Novel Three-Finger Toxin Sodium Channel Activators from the Venom of the Long-Glanded Blue Coral Snake (Calliophis bivirgatus).
    Yang DC; Deuis JR; Dashevsky D; Dobson J; Jackson TN; Brust A; Xie B; Koludarov I; Debono J; Hendrikx I; Hodgson WC; Josh P; Nouwens A; Baillie GJ; Bruxner TJ; Alewood PF; Lim KK; Frank N; Vetter I; Fry BG
    Toxins (Basel); 2016 Oct; 8(10):. PubMed ID: 27763551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium Channels and Venom Peptide Pharmacology.
    Israel MR; Tay B; Deuis JR; Vetter I
    Adv Pharmacol; 2017; 79():67-116. PubMed ID: 28528674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venom-derived peptide inhibitors of voltage-gated potassium channels.
    Norton RS; Chandy KG
    Neuropharmacology; 2017 Dec; 127():124-138. PubMed ID: 28689025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Block of voltage-gated calcium channels by peptide toxins.
    Bourinet E; Zamponi GW
    Neuropharmacology; 2017 Dec; 127():109-115. PubMed ID: 27756538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A complicated complex: Ion channels, voltage sensing, cell membranes and peptide inhibitors.
    Zhang AH; Sharma G; Undheim EAB; Jia X; Mobli M
    Neurosci Lett; 2018 Jul; 679():35-47. PubMed ID: 29684532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tarantula toxin β/δ-TRTX-Pre1a highlights the importance of the S1-S2 voltage-sensor region for sodium channel subtype selectivity.
    Wingerd JS; Mozar CA; Ussing CA; Murali SS; Chin YK; Cristofori-Armstrong B; Durek T; Gilchrist J; Vaughan CW; Bosmans F; Adams DJ; Lewis RJ; Alewood PF; Mobli M; Christie MJ; Rash LD
    Sci Rep; 2017 Apr; 7(1):974. PubMed ID: 28428547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venom Peptides From Cone Snails: Pharmacological Probes for Voltage-Gated Sodium Channels.
    Green BR; Olivera BM
    Curr Top Membr; 2016; 78():65-86. PubMed ID: 27586281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid-sensing ion channel (ASIC) structure and function: Insights from spider, snake and sea anemone venoms.
    Cristofori-Armstrong B; Rash LD
    Neuropharmacology; 2017 Dec; 127():173-184. PubMed ID: 28457973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PF-06526290 can both enhance and inhibit conduction through voltage-gated sodium channels.
    Wang L; Zellmer SG; Printzenhoff DM; Castle NA
    Br J Pharmacol; 2018 Jul; 175(14):2926-2939. PubMed ID: 29791744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype Specificity of β-Toxin Tf1a from
    Mata DOD; Tibery DV; Campos LA; Camargos TS; Peigneur S; Tytgat J; Schwartz EF
    Toxins (Basel); 2018 Aug; 10(9):. PubMed ID: 30131471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spider Knottin Pharmacology at Voltage-Gated Sodium Channels and Their Potential to Modulate Pain Pathways.
    Dongol Y; Cardoso FC; Lewis RJ
    Toxins (Basel); 2019 Oct; 11(11):. PubMed ID: 31671792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of sea anemone type 1 neurotoxins on voltage-gated sodium channel isoforms.
    Wanke E; Zaharenko AJ; Redaelli E; Schiavon E
    Toxicon; 2009 Dec; 54(8):1102-11. PubMed ID: 19393679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal toxins influence voltage-gated sodium channel function.
    Gilchrist J; Olivera BM; Bosmans F
    Handb Exp Pharmacol; 2014; 221():203-29. PubMed ID: 24737238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Voltage-Gated Sodium Channel Peptide Toxins from Animal Venom: Pharmacological Probes and Analgesic Drug Development.
    Wu Y; Ma H; Zhang F; Zhang C; Zou X; Cao Z
    ACS Chem Neurosci; 2018 Feb; 9(2):187-197. PubMed ID: 29161016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Where cone snails and spiders meet: design of small cyclic sodium-channel inhibitors.
    Peigneur S; Cheneval O; Maiti M; Leipold E; Heinemann SH; Lescrinier E; Herdewijn P; De Lima ME; Craik DJ; Schroeder CI; Tytgat J
    FASEB J; 2019 Mar; 33(3):3693-3703. PubMed ID: 30509130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-3 toxins and cardiac sodium channels.
    Hanck DA; Sheets MF
    Toxicon; 2007 Feb; 49(2):181-93. PubMed ID: 17092528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical engineering and structural and pharmacological characterization of the α-scorpion toxin OD1.
    Durek T; Vetter I; Wang CI; Motin L; Knapp O; Adams DJ; Lewis RJ; Alewood PF
    ACS Chem Biol; 2013; 8(6):1215-22. PubMed ID: 23527544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Tale of Toxin Promiscuity: The Versatile Pharmacological Effects of Hcr 1b-2 Sea Anemone Peptide on Voltage-Gated Ion Channels.
    Pinheiro-Junior EL; Kalina R; Gladkikh I; Leychenko E; Tytgat J; Peigneur S
    Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads.
    Klint JK; Senff S; Rupasinghe DB; Er SY; Herzig V; Nicholson GM; King GF
    Toxicon; 2012 Sep; 60(4):478-91. PubMed ID: 22543187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.